Semglee Injection, Solution
Product Images NDC 83257-012

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Semglee (NDC 83257-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Site Of Injection On Body (Image 01)

Illustration showing recommended subcutaneous injection sites for SEMGLEE (insulin glargine-yfgn) injection solution. Highlighted areas include the upper arms, abdomen, and front and sides of the thighs on a human figure.*

FDA Label Image

Instructions For Use Step 1 (Image 02)

An instructional illustration showing a hand holding a vial, with a syringe drawing solution from the vial through a needle. The image demonstrates the proper technique for withdrawing medication from a vial using a syringe.*

FDA Label Image

Instructions For Use Step 2 (Image 03)

Illustration showing a close-up of hands preparing an injection vial for use. One hand is holding the vial while the other inserts or removes a vial stopper with a tab. The image focuses on proper handling technique for injection preparation.*

FDA Label Image

Instructions For Use Step 3 (Image 04)

Instructional illustration showing a syringe held by a hand drawing solution from a vial, followed by an image of a needle being attached to the syringe by twisting. The diagrams depict steps for preparing an injection.*

FDA Label Image

Instructions For Use Step 4 (Image 05)

An instructional illustration showing hands handling a syringe with a cap being removed or adjusted. The image depicts a step in preparing an injection, likely related to the subcutaneous administration process of SEMGLEE insulin glargine-yfgn injection, solution 100 units/mL by Biocon Biologics Inc.*

FDA Label Image

Instructions For Use Step 5 (Image 06)

An instructional illustration showing a hand holding a vial and a syringe, demonstrating the process of drawing liquid from the vial into the syringe for injection preparation.*

FDA Label Image

Instructions For Use Step 7 (Image 07)

An instructional illustration showing hands preparing to administer a subcutaneous injection using a syringe or pen device. One hand is holding the injection device while the other hand pinches the skin to form a fold, demonstrating proper injection technique.*

FDA Label Image

Instructions For Use Step 8 (Image 08)

An instructional diagram showing two hands holding an insulin pen device for injection. The illustration appears to demonstrate preparing or administering a subcutaneous injection, relevant to the SEMGLEE insulin glargine-yfgn 100 IU/mL injection solution by Biocon Biologics Inc.*

FDA Label Image

Instructions For Use Pen (Image 09)

An illustration of the SEMGLEE insulin glargine-yfgn injection pen components and their assembly. The diagram labels parts including the pen cap, cartridge holder, cartridge with rubber seal, pen body, insulin type indicator, expiration date window, dose pointer, dose window, dose knob, and injection button. Additional components like the pen needle with outer and inner caps, needle, and protective seal are shown but not included with the pen.*

FDA Label Image

Instructions For Use Figure A (Image 10)

SEMGLEE insulin glargine-yfgn injection, 100 units per mL, shown in a pen injector device. The label on the pen includes the brand name SEMGLEE and specifies the human prescription drug for subcutaneous use. The manufacturer is Biocon Biologics Inc.*

FDA Label Image

Instructions For Use Figure B (Image 11)

SEMGLEE 100 IU/mL insulin glargine-yfgn injection pen in solution form, designed for subcutaneous use. The image shows a close-up of the blue prefilled pen device manufactured by Biocon Biologics Inc., including a portion of the label indicating lot number and expiration date fields.*

FDA Label Image

Instructions For Use Figure C (Image 12)

An instructional illustration showing a hand removing or sliding off the safety cap from a syringe filled with injection solution, preparing it for use. The syringe is marked with measurement lines and numbers, indicating dosage volume.*

FDA Label Image

Instructions For Use Figure D (Image 13)

SEMGLEE insulin glargine-yfgn injection, 100 units/mL (U-100) in a clear prefilled syringe with volume markings. The label on the syringe includes the brand name Semglee, concentration, and specifies use for single patient only. The product is manufactured by Biocon Biologics Inc.*

FDA Label Image

Instructions For Use Figure E (Image 14)

An instructional illustration showing a hand holding the cap above the neck of a vial, positioned for removal. The vial has volume markings visible, including 20 and 60, suggesting measurement graduations on the vial's body.*

FDA Label Image

Instructions For Use Figure F (Image 15)

An instructional illustration depicts the removal of a paper or foil seal from the top of a vial by lifting the tab, showing fingers gripping the vial and peeling back the seal cover.*

FDA Label Image

Instructions For Use Figure G (Image 16)

An instructional illustration showing how to prepare a syringe for use. It depicts fingers holding the syringe and twisting the needle cap to remove it, with arrows indicating the direction of movement. A circular inset highlights the grip on the needle cap during removal.*

FDA Label Image

Instructions For Use Figure H (Image 17)

Instructional illustration showing the removal of a syringe cap while advising to keep the outer cap. The image highlights proper handling of injection components for SEMGLEE insulin glargine-yfgn injection, solution, 100 units/mL, by Biocon Biologics Inc.*

FDA Label Image

Semglee Injection 100 Units/ml Pen Carton (Image 18)

Packaging label for Semglee (insulin glargine-yfgn) injection, 100 units/mL (U-100), in 3 mL prefilled pens. The label shows the brand name, generic name, strength, dosage form, instructions for single patient use, and manufacturer Biocon Biologics Inc. The label includes barcodes and warnings, with a color scheme featuring blue, white, and pink accents.*

FDA Label Image

Semglee Injection 100 Units/ml Vial Carton (Image 19)

Packaging label of Semglee (insulin glargine-yfgn) injection 100 units/mL (U-100), a subcutaneous injection solution. The label indicates a 10 mL multiple-dose vial, with instructions not to mix with other insulins and that the solution must be clear and colorless. The labeler is Biocon Biologics Inc. Storage directions and additional product details are also included.*

FDA Label Image

Figure 1: Activity Profile In Patients With Type 1 Diabetes (Image 20)

A line graph comparing glucose infusion rates over time after subcutaneous injection for Insulin glargine and NPH insulin. The x-axis shows time in hours up to 30, and the y-axis shows glucose infusion rate in mg/kg/min. Insulin glargine shows a relatively flat infusion rate, while NPH insulin peaks earlier and declines. Markers indicate end of observation periods for both.*

FDA Label Image

Instructions For Use Figure I (Image 21)

An instructional illustration showing hands removing the inner cap from a syringe needle, with an arrow indicating the direction to throw away the inner cap into a sharps disposal container. This image is part of injection preparation instructions for SEMGLEE insulin glargine-yfgn 100 units/mL solution for subcutaneous injection.*

FDA Label Image

Instructions For Use Figure J (Image 22)

An instructional illustration showing a close-up of a dosing dial adjustment on a medication injection pen. The visible numbers on the dial range from 0 to 4, indicating dose units, and a white knob with grip lines is shown for setting the dose.*

FDA Label Image

Instructions For Use Figure K (Image 23)

An instructional illustration showing a hand holding a SEMGLEE injection pen. The image highlights the step of attaching a needle to the pen, indicated by an arrow pointing upward, with a close-up inset of a needle being connected to the pen cap.*

FDA Label Image

Instructions For Use Figure L (Image 24)

The image shows a Semglee insulin glargine-yfgn injection syringe, solution for subcutaneous use. The syringe is labeled with Semglee branding and strength of 100 units per mL. It features a transparent barrel with measurement markings and a blue label indicating the product and its manufacturer, Biocon Biologics Inc.*

FDA Label Image

Instructions For Use Figure M (Image 25)

An instructional illustration showing two hands holding a Semglee (insulin glargine-yfgn) injection pen. The pen is labeled for subcutaneous use and indicates a 100 units/mL concentration, highlighting details relevant for dosage and administration.*

FDA Label Image

Instructions For Use Figure N (Image 26)

An instructional image showing a close-up of a dosage selector dial marked with large numbers, highlighting the number 48. The text above reads, "Example of 48 units selected," indicating a dosage selection likely related to insulin administration.*

FDA Label Image

Instructions For Use Figure O (Image 27)

An instructional illustration showing a close-up view of a dosing dial set to approximately 49 units with prominent markings at 48 and 50 units. The image includes the text 'Example of 49 units selected,' demonstrating dose selection, likely related to insulin injection use.*

FDA Label Image

Instructions For Use Figure P (Image 28)

Illustration showing how to hold a syringe labeled SEMGLEE insulin glargine-yfgn 100 units/mL for subcutaneous injection. The image depicts a hand gripping the syringe with the needle positioned near the abdominal area, with an arrow indicating the injection direction.*

FDA Label Image

Instructions For Use Figure Q (Image 29)

An instructional illustration showing a hand holding a syringe with a dose dial. It includes two close-up views: one correct method of aligning the dial to a dose marking, and one incorrect method marked with an X, demonstrating proper dose setting technique for injection.*

FDA Label Image

Instructions For Use Figure R (Image 30)

An instructional illustration showing a hand holding a syringe or pen device for injecting SEMGLEE insulin glargine-yfgn. A zoomed-in circular inset highlights a timer set to 10 seconds, suggesting to hold the injection for this duration.*

FDA Label Image

Instructions For Use Figure S (Image 31)

An instructional illustration showing a hand removing a protective cap from the needle of an injection pen containing a clear solution. The pen is labeled with measurement markings indicating dosage levels. A downward arrow guides the cap removal action.*

FDA Label Image

Instructions For Use Figure T (Image 32)

An instructional illustration depicting a hand rotating the cap of a vial labeled with the number 1, followed by an upward arrow labeled with the number 2, indicating steps for opening or removing the vial cap. No text other than the numbers and arrows is visible.*

FDA Label Image

Instructions For Use Figure U (Image 33)

An instructional illustration depicting hands removing a cap from the top of a vial marked with volume measurements, positioned next to a sharps disposal container with a biohazard symbol. The image demonstrates proper vial handling before injection.*

FDA Label Image

Instructions For Use Figure V (Image 34)

An instructional illustration showing a hand removing the cap from a syringe filled with a clear liquid. The syringe is marked with dosage measurement lines and a needle at the tip. An arrow points from the cap towards the syringe, indicating the action of cap removal.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.